Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

Overview of attention for article published in Lancet Infectious Diseases, September 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 6 news outlets
policy: 1 policy source
twitter: 64 X users
patent: 1 patent

facebook: 3 Facebook pages
googleplus: 1 Google+ user
guideline: 1 clinical guideline source

Readers on

mendeley: 190 Mendeley

So far, Altmetric has seen 6 news stories from 6 outlets.

Transgenic Cows Produce 'Safe' Trial Therapy for MERS

newsmax.com, 10 Jan 2018

An experimental treatment for deadly Middle East Respiratory Syndrome (MERS) has been manufactured in cattle carrying human DNA…

Transgenic cows produce 'safe' trial therapy for MERS

Emirates 24/7, 10 Jan 2018

An experimental treatment for deadly Middle East Respiratory Syndrome (MERS) has been manufactured in cattle carrying human DNA…

Transgenic cows produce 'safe' trial therapy for MERS

Yahoo!, 10 Jan 2018

In the trial, cattle were injected with part of the MERS virus, stimulating their immune system to produce antibodies which…

Transgenic cows produce 'safe' trial therapy for MERS

Jamaice Oberserver, 10 Jan 2018

PARIS, France (AFP) — An experimental treatment for deadly Middle East Respiratory Syndrome (MERS) has been manufactured in…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 2 additional news stories.